A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Southern California
University of Washington
Massachusetts General Hospital
University of Miami
Icahn School of Medicine at Mount Sinai
Thomas Jefferson University
Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
PharmaEssentia
City of Hope Medical Center
RWTH Aachen University
Italfarmaco
M.D. Anderson Cancer Center
Ottawa Hospital Research Institute
Sierra Oncology LLC - a GSK company
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Incyte Corporation
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Sierra Oncology LLC - a GSK company
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Italfarmaco
M.D. Anderson Cancer Center
Swiss Cancer Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Galena Biopharma, Inc.
Icahn School of Medicine at Mount Sinai
Hospital Israelita Albert Einstein
Geron Corporation
Northside Hospital, Inc.
Mayo Clinic
Teva Branded Pharmaceutical Products R&D, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Baylor College of Medicine
University of California, San Francisco
European Organisation for Research and Treatment of Cancer - EORTC
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Copenhagen University Hospital at Herlev